Business Wire

FourKites Releases New Capabilities for Global Air Freight Visibility

9.5.2023 09:00:00 EEST | Business Wire | Press release

Share

Leading supply chain visibility company FourKites has introduced several powerful new capabilities to enhance air freight visibility around the globe. These new features, including industry-leading dashboards and unique views into carrier events, split shipments and booking details, complement FourKites’ existing end-to-end international visibility solutions to help shippers proactively build routes based on in-transit inputs, all in a single user interface.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230508005742/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

FourKites Releases New Capabilities for Global Air Freight Visibility (Photo: Business Wire)

Heavyweight air is commonly used by shippers and freight forwarders to transport high-value goods, as well as to expedite shipments when delays occur. Now, FourKites’ unmatched data intelligence and enhanced air solutions help shippers optimise their supply chain faster and with greater accuracy than ever before — all seamlessly on the FourKites platform via end-to-end multimodal visibility.

New notable air visibility features provide the following benefits:

  • Carrier Events View allows shippers to compare data from carrier websites against FourKites’ milestones, events and highly accurate Dynamic ETAs® for Air that leverage machine learning and AI algorithms. This allows supply chain partners to increase workforce efficiencies and maximise collaboration based on high-quality, end-to-end visibility data.
  • Easy Load Creation enables shippers to generate air shipments with limited information, thereby accelerating their time to value with visibility.
  • New Dashboards — including a Transit Time Dashboard, On-time Performance Dashboard, Milestone Dashboard, Customer Health Dashboard and Lane Dashboard — allow for more strategic decision-making through insights on carrier and lane performance, tracking health and more.
  • Split Shipments let customers track shipments that have been split onto different flights or routes, and monitor quantity and weight at the flight level. This provides enhanced visibility into inventory levels, empowering shippers to improve resource planning and pickup scheduling.
  • Booking Details — including flight number, status, origin/destination, arrival/departure time, quantity, weight and volume — provide clear visibility into the flight expectations compared to the tracking updates happening in real time.

“FourKites continues to be an essential partner in our ability to help our customers make informed freight forwarding decisions, keeping their timelines precise and costs under control,” said Chad Heller, Executive Vice President, Global Development at Pegasus Logistics. “We look forward to leveraging FourKites’ new air visibility solutions to strengthen supply chain logistics and enhance customer experiences around the globe.”

These new capabilities build upon FourKites’ recent significant expansion in air freight. Over the last 12 months, the company has experienced over 150% growth in air volume, and now tracks across more than 100 airlines and 17,000 airports, integrating with more than 20 major parcel providers to support high-value shipments. In addition, customers continue to benefit from FourKites’ Dynamic ETA for Air — the industry-first innovation that tracks nearly 100% of air freight with highly accurate and automated ETAs within 9 hours of arrival.

“By offering true door-to-door air visibility, FourKites is focused on providing the full picture to help customers transport high-value freight efficiently,” said Priya Rajagopalan, chief product officer at FourKites. "Shippers and freight forwarders often rely on air to transport valuable goods and to speed up shipments in case of delays. FourKites’ new capabilities, created in close collaboration with our customers, represent a meaningful step forward in integrating air transport more efficiently in global supply chains."

FourKites’ new air offerings are part of the company’s international solution suite that comprises ocean, air and rail, connecting global end-to-end supply chains through real-time visibility technology that helps shippers, carriers and 3PLs work better together. Similar to air visibility, FourKites’ Dynamic Ocean ® also includes Dynamic ETAs powered by artificial intelligence, providing customers with the market’s most accurate ETAs for ocean shipments across all lanes worldwide.

About FourKites

Leading supply chain visibility platform FourKites® extends visibility beyond transportation into yards, warehouses, stores and beyond. Tracking more than 3 million shipments daily across road, rail, ocean, air, parcel and last mile, and reaching over 200 countries and territories, FourKites combines real-time data and powerful machine learning to help companies digitise their end-to-end supply chains. More than 1,200 of the world’s most recognised brands — including 9 of the top-10 CPG and 18 of the top-20 food and beverage companies — trust FourKites to transform their business and create more agile, efficient and sustainable supply chains. To learn more, visit https://www.fourkites.com/.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Scott Johnston
European PR Director, FourKites
+31 62 147 8442
scott.johnston@fourkites.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 17:18:00 EEST | Press release

Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 15:30:00 EEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu ® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 14:45:00 EEST | Press release

Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522587414/en/ Selected from 393 submissions across 68 countries, the winning teams were recognised through the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve. Health systems globally are facing rising costs and persistent delays in diagnosis, with many conditions still identified only after symptoms become severe. At the sam

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye